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Amosite and Chrysotile Asbestos in Syrian
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by Ernest E. McConnell,* Alan M. Shefner,t John H. Rustt and
John A. Moore*
Bioassays of amosite, short-range (SR), intermediate-range (IR) or intermediate-range
chrysotile asbestos in combination with the intestinal carcinogen 1,2-dimethylhydrazine
dihydrochloride (DMH) were conducted with male and female Syrian golden hamsters.
Amosite and both forms of chrysotile asbestos were administered at a concentration of
1% in pelieted diet for the entire lifetime ofthe hamsters starting with mothers ofthe test
animals. Group sizes varied from 125-254. There was no adverse effect on body weight
gain or survival by either type of asbestos or by IR chrysotile asbestos in combination
with DMH.
A significant increase (p < 0.05) in adrenal cortical tumors was observed in male
hamsters exposed to SR and IR chrysotile asbestos and in females treated with IR
chrysotile asbestos when compared to the pooled control groups. However, statistical
significance (p < 0.05) was lost when these dosed groups were compared with temporal
control groups. Neither ofthe male or female amosite asbestos groups showed increased
neoplasia in any tissue or organ compared to the control groups. The cocarcinogen
studies using IR chrysotile asbestos and 1,2-dimethylhydrazine dihydrochloride were
considered inadequate because there was no increase in intestinal neoplasia in the DMH
group.
Introduction
In November 1973 the National Institute of
Environmental Health Sciences and the Environ-
mental Protection Agency cosponsored a sympo-
sium on the possible biological effects ofingested
asbestos (1). This conference concluded that a
paucity of definitive data existed concerning the
effects of ingested asbestos and that specific re-
search was needed.
A subcommittee of the DHEW Committee to
Coordinate Tbxicology and Related Programs was
established to review existing data and to prepare
a draft research protocol that would be responsive
to the possible public health implication of in-
gested asbestos. This protocol was widely distrib-
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uted for comment within and outside the govern-
ment and a public meeting of the subcommittee
was held on February 11, 1975. On the basis of
the comments received, a revised final protocol
was developed which called for the use of long-
term animal toxicology studies to evaluate the
ingestion of several minerals for carcinogenic ef-
fect. As a result the National Toxicology Program
investigated the carcinogenic potential ofthe in-
gestion of various forms of asbestos in rats and
hamsters. All of the studies were to encompass
the lifetime ofthe animal, including exposure of
the dams from which the test animals were de-
rived.
This report represents the results of studies
undertaken to determine the effects ofthe inges-
tion of amosite and chrysotile (short- and inter-
mediate-range) asbestos in Syrian golden ham-
sters. Theeffects ofintermediate-range chrysotile
asbestos in conjunction with a known intestinal
carcinogen, 1,2-dimethylhydrazine (DMH), were
also studied.McCONNELL ET AL.
Table 1. Fiber characteristics ofchrysotile asbestos.
Fiber characteristics Short-range Intermediate-range
Surface area, m2/g 59.0 27.9
Density, g/cm3 2.577 ± 0.022 SD 2.607 ± 0.016 SD
Measurement, transmission electron microscopy
Fiber count/g 0.6081 x 1013 0.1291 x 1012
Median length, gim 0.66 0.82
Range oflength, gm 0.088-51.1 0.104-783
Median diameter, gm 0.059 0.089
Range ofdiameter, gm 0.019-1.57 0.019-11.5
Median fiber aspect ratio (L/D) 11.1698 8.435
Frequency distribution by length (jim), optical microscopy
10 percentile 1.3 1.4
20 percentile 1.7 1.9
30 percentile 2.2 3.0
40 percentile 2.6 5.4
50 percentile 3.1 14.0
60 percentile 3.8 29.0
70 percentile 4.5 48.0
80 percentile 5.8 76.0
90 percentile 7.8 130.0
Materials and Methods
Asbestos is a general term applied to certain
natural mineral silicates when they appear in a
fibrous form. Chrysotile is the fibrous member of
the serpentine mineral group while amosite is an
amphibole mineral. Two chrysotile test materials
were selected for testing and are referred to as
short-range (SR) and intermediate-range (IR)
chrysotile. Intermediate-range chrysotile differs
from short-range chrysotile in that the former
contains fibers extending into relatively large
sizes, both with respect to length and diameter.
The short-range chrysotile was purchased from
the Union Carbide Corporation, Niagara Falls,
New York, which referred to the material as COF-
25. The chrysotile was mined from the New Idria
serpentine mass located in the southwestern San
Benito and western Fresno counties ofCalifornia.
Mineral and fiber characteristics ofSR chrysotile
are shown in Tables 1 and 2.
The intermediate-range chrysotile was pur-
chased from the Johns Manville Company, which
referred to the material as Plastobest-20. The
chrysotile was obtained from the Jeffrey Mine,
Asbestos, Quebec, Canada. Mineral and fiber
characteristics of IR chrysotile are shown in Ta-
bles 1 and 2.
An amosite sample (S-33) from a mine in
Penge, Transvaal, Republic of South Africa was
purchased by the Bureau ofMines from the Atlas
Asbestos Company, Montreal, Quebec, Canada.
The sample was processed by a single pass
through an airjet mill to improve the homogene-
ity ofthe amosite. Mineral and fiber characteris-
tics ofamosite are shown in Tables 3-5.
Table 2. Chemical-instrumental analyses ofchrysotile
asbestos.
Content, wt-%
Short-range Intermediate-range
A1203 0.66
CaO 0.32
Fe2O3 2.02
MgO 40.62
K20 Not detected
SiO2 39.77
Na2O 0.01
TiO2 0.03
MnO 0.07
Cr2O3 0.17
NiO 0.17
C0203 0.01
CO2 0.78
H20 1.54
H2O+ 12.69
Benzene-extracted organics 0.026
1.47
0.05
2.93
40.62
0.08
39.90
0.04
0.04
0.06
0.06
0.06
Not detected
0.51
1.17
12.81
0.011
The homogenicity ofthe samples andthe physi-
cal and chemical properties ofthe materials were
extensively characterized by the Bureau of
Mines, U.S. Department ofthe Interior (Supt. of
Documents No. I 28.23:8452) and by the Fine
Particle Laboratories, Illinois Institute of Tech-
nology Research Institute, Chicago, Illinois (Spe-
cial Report and Addendum on project L6085, con-
tract Nol-ES-5-3157). Copies ofthese reports are
available upon request from the National lbxicol-
ogy Program.
Test Diets
The feed used was NIH-31 open formula rodent
diet prepared by Zeigler Brothers, Inc., Gardner,
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PA. The appropriate asbestos was incorporated to
a level of1% by weight into the test diet. All feed
was pelleted with a Sprout-Waldron pelleter; the
pellets were ofoval configuration, 3I8 in. by 3/4 in.
in size. Pelleted feed was packaged in 25-lb ali-
quots in standard paper feed-bags which were
color coded to minimize the occurrence offeeding
Table 3. Fiber characteristics ofamosite asbestos.
Fibercharacteristics
Surface area, m2/g 4.13
Density, g/cm3 3.35 ± 0.026 SD
Measurements, transmission electron microscopy
Fibercount/g 0.3466 x 1010
Medianlength,gm 4.37
Range oflength,gim 0.85-995
Mediandiameter,jgm 0.72
Rangeofdiameter,gim 0.064-12.4
Medianfiber aspect ratio (LID) 6.4248
Table 4. Chemical-instrumental asbestos ofamosite
asbestos.
A1203 0.42
CaO 0.48
FeO 34.61
Fe2O3 2.24
MgO 6.22
K20 0.30
SiO2 50.36
Na2O 0.03
MnO 2.66
Cr2O3 0.03
NiO 0.01
CO2 0.88
H20 0.15
errors at the test laboratory. Each lot ofblended
feed was analyzed for asbestos concentration.
Sources and Specifications ofTest
Animals
Four groups (three chrysotile and one amosite)
of disease-free, mated female outbred Syrian
goldenhamsters were obtainedover aperiodof20
weeks in 1977 from Charles River Lakeview Lab-
oratories, New Field, NJ. The hamsters had been
mated 6 days prior to shipping.
Animal Maintenance
Upon arrival, the mated female hamsters were
weighed and sorted into weight ranges. They
were then distributed randomly between control
and treatment groups, which were housed in sep-
arate rooms. The first shipment ofmated females
was assigned to the short-range (SR) chrysotile
study, the second to the intermediate-range (IR)
chrysotile study, the third shipment to the IR
chrysotile plus DMH study, the fourth group to
the amosite study and their respective control
groups. Each dam was placed in~an individual
cage with filtertop in itsrespectiv&ei'rom. Control
or formulated diets were provided ad libitum on
the floor of each cage. Water was provided ad
libitum via bottles. The hamsters were not han-
dled just before the litters were due to be born
except when the cages were changed. Once the
litterswereborn, theywere leftundisturbeduntil
they were approximately 10 days of age. Then,
the cages were changedweeklyuntilthe offspring
Table 5. Particle size distribution ofamosite asbestos by particle number: SEM.a
Length interval, jm
0-1.99 2-3.99 4-5.99 6-7.99 8-9.99 10-19.99 20-39.99
Amosite mean width, jim.
Amosite particles per interval
Total amosite particles, %
Cumulative amosite, %
Amosite, vol.-%
Cumulative vol-% amosite
Number ofother particles
Amosite particles per length interval, % by
aspect ratio:
1:1-2.9:1
3:1-4.9:1
5:1-9.9:1
10:1-19.9:1
20:1-49.9:1
50:1-99.9:1
100:1-199:1
200:1-499:1
>500:1
0.28 0.38
57 126
5.6 12.3
5.6 17.9
- 0.1
- 0.1
11 8
0.45
83
8.6
26.5
0.3
0.4
1
0.45
78
7.6
34.1
0.4
0.8
0
0.48
52
5.1
39.2
0.4
1.2
1
12 0 0 0 0
34 10 6 5 2
43 52 23 14 4
11 34 52 38 40
0 4 18 41 54
0 0 1 2 0
0 0 0 0 0
0 4 0 0 0
0 0 0 0 0
aCalculated from particle number data, assuming rectangular cross section with third dimension equal to 1/2 measured width.
0.52
181
17.7
56.9
2.4
3.6
1
0.51
184
18.0
74.9
5.0
8.6
0
0
0
1
21
64
12
2
0
0
0
0
1
1
30
55
12
1
0
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were 4 weeks of age, at which time they were
weaned.
At weaning, the offspring were individually
weighed and separated by sex. The test groups
were randomly placed into groups ofthree males
and three females and housed in polycarbonate
cages for the remainder ofthe lifetime study. The
dams were killed at this time. Twenty male and
twenty female offspring were removed from the
study for endo- and ectoparasite examination to
confirm that the test groups were of a desired
health status. Extra hamsters were not discarded
at this time, in case animals had been missexed.
Approximately 6 weeks after weaning, all mis-
sexed hamsters were killed along with their cage
mates and were replaced with these alternates
which had received maintenance identical to that
receivedby the original hamsters. The remaining
hamsters were killed. The experimental design
insured that ingestion of asbestos spanned the
entire phase ofsolid food consumption during the
lifetime ofthe animal. Food consumption was not
determined because of the hamster's habit of se-
questering its feed in the bedding. Control ham-
sters were housed in separate rooms. The number
ofanimals in the study is shown in Table 6.
Starting at 6 weeks of age, male and female
hamsters in the intermediate-range chrysotile/
1,2-dimethylhydrazine dihydrochloride (DMH)
study (Table 1) were given oral doses of DMH (4
mg/kg) every otherweek for atotal of5 doses. The
dose ofDMH used in this study was based on the
results of a pilot study carried out previously in
the same facility. The latter was conducted in a
manner similar to that reported in rats (2). The
DMH (Aldrich Chemical Co., Milwaukee, WI)
was used as received and was dissolved in 0.9%
saline to aconcentration of1.5% (15 mg/mL). This
stocksolution wasthendilutedwith saline to give
the appropriate concentration for dosing. The so-
lutions were made up within one hour prior to the
dosing ofthe hamsters. All dosing was completed
in less than 3 hr. The DMH was analyzed after
each dosing.
During the test period, room temperature was
maintained at 22 + 2°C and the relative humid-
ity rangedfrom 40% to 80%. Ib minimize contam-
ination of room air with asbestos, each cage was
totally enclosed. Incoming air was filtered to the
cages through glass fiber filters while exit air was
filtered through a fiberglass roughing filter fol-
lowed by a bag housing filter. The cage atmo-
sphere was negative relative to the room and the
room wasmaintained at aslightlynegative atmo-
sphere in relation to corridor air. Air flow within
the animal rooms was maintained with a mini-
mum of 20 air changes/hr. Flourescent lighting
was provided 12 hr/day.
Clinical Examinations and Pathology
All hamsters were observed daily for signs of
toxicity. Body weights ofindividual animals were
recorded weekly for the duration ofthe study. All
animals were allowed to die or were killed with
pentobarbital sodium when moribund. A com-
plete postmortem examination was performed on
all animals not severely cannibalized or auto-
lyzed. Thus, the number of animals from which
particular organs or tissues were examined mi-
Table 6. Disposition ofhamsters in oral asbestos study.
Histopathologic
Group Sex On test evaluation Missing Cannibalized Autolyzed Missexed
SR chrysotile M 126 115 0 3 6 2
control F 126 114 0 1 6 5
IR chrysotile M 126 116 0 0 8 2
control F 126 119 0 0 4 3
DMH and IR chrysotile M 125 119 0 0 3 3
control F 128 120 1 0 2 5
Amosite M 127 122 0 0 4 1
control F 126 119 1 0 1 5
SR chrysotile M 253 233 0 1 10 9
F 252 228 1 0 17 6
IR chrysotile M 251 245 0 0 3 3
F 252 244 1 0 3 4
DMH M 127 127 0 0 0 0
F 126 122 0 0 1 3
DMH and IR M 176 173 0 0 2 1
chrysotile F 174 161 3 0 6 4
Amosite M 252 248 0 0 3 1
F 254 237 5 0 5 7
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croscopically varies and does not necessarily rep-
resent the number ofanimals that were placed on
study in each group (Table 6).
Since the gastrointestinal tract was chosen as
one ofthe target organs prior to the study, it was
handled in a manner slightly different from the
usual in standard rodent lifetime bioassays. Prior
toplacement infixative, the entire esophagus was
opened and pinned with the exterior surface adja-
cent to cardboard. The stomach and cecum were
prepared similarly. Lengths ofduodenum and il-
eum (2 cm) and two portions of jejunum were
placed unopened in fixative. The remaining small
intestine was opened and gently washed with
saline and it was then carefully examined. Sus-
pect lesions were processed separately and identi-
fied individually as to location. Likewise, the en-
tire colon with anus was opened, examined, and
pinnedtocardboardpriortofixation. The size and
location ofmasses were recorded. Masses greater
than 1 mm in diameter were removed as separate
specimens for processing. After fixation and prior
to embedding, the colon was "carpet-rolled" start-
ing atthe posterior end, with the mucosal surface
inward.
All tissues were fixed in 10% neutral buffered
formalin, sectioned, and stained with hematoxy-
lin and eosin. Tissues/organs examined micro-
scopically were: tissue masses, the above men-
tioned portions of gastrointestinal tract,
mesenteric and bronchial lymph nodes, mam-
mary gland, salivary gland, thigh muscle, bone
marrow (sternum), nasal cavity with turbinates,
larynx, trachea, lungs, and bronchi, heart, thy-
roid, parathyroid, liver, gallbladder, pancreas,
spleen, kidneys, adrenal glands, urinary bladder,
seminal vesicles/prostate/testes, ovaries/uterus,
brain, pituitary gland, eyes and spinal cord. Se-
lected sections were stained with Bennhold's
congo red to demonstrate amyloid.
Data Recording and Statistical
Methods
The individual animal pathology data on this
experiment were recorded in the Carcinogenesis
Bioassay DataSystem. Thedataelements include
descriptive information on the chemicals, ani-
mals, experimental design, clinical observations,
survival, and individual pathologic results.
Probabilities ofsurvival were estimated by the
product-limit procedure ofKaplan and Meier (3).
Animals were statistically censored asofthe time
that they died of other than natural causes or
were found to be missing; animals dying from
natural causes were not statistically censored.
Differences in survival were evaluated by Cox's
life table method (4).
The incidence of neoplastic or nonneoplastic
lesions has been given as the ratio ofthe number
ofanimals bearing such lesions at a specific ana-
tomic site (numerator) to the number of animals
in which that site was examined (denominator).
In most instances, the denominators included
only those animals for which that site was exam-
ined histologically. However, when macroscopic
examination was required to detect lesions (e.g.,
skin ormammarytumors) priortohistologic sam-
pling, or when lesions could have appeared at
multiple sites (e.g., lymphomas), the denomina-
tors consist ofthe numbers ofanimals necropsied.
For the statistical analysis of tumor incidence
data, two different methods ofadjusting for inter-
current mortality were employed. Each used the
classical methods for combining contingency ta-
bles developed by Mantel and Haenszel (5).
The first method of analysis assumed that all
tumors ofa given type were fatal, i.e., they either
directly or indirectly caused the death of the
animal. According to this approach, the propor-
tions oftumor-bearing animals in the treated and
control groups were compared at each point in
time at which an animal died with a tumor of
interest. The denominators of these proportions
were the total number ofanimals at risk in each
group. These results were then combined by the
Mantel-Haenszel methods to obtain an overall
probability (p) value. This method ofadjusting for
intercurrent mortality is Cox's life table method
(4).
The second method ofanalysis assumed that all
tumors ofa given type were "incidental," i.e., they
were merely observed at autopsy in animals dy-
ing of an unrelated cause. According to this ap-
proach, the proportions ofanimals found to have
tumors in treated and control groups were com-
pared in each of five time intervals. For male
hamsters these time intervals were 0-52 weeks,
53-78 weeks, 79-92 weeks, 93-103 weeks and
beyond 103 weeks. For female hamsters whose
median survival was considerably less than that
ofthe males, the time intervals were 0-44 weeks,
45-52 weeks, 53-60 weeks, 61-68 weeks and be-
yond68 weeks. The denominators ofthesepropor-
tions were the number ofanimals actually autop-
siedduringthe time interval. The individual time
interval comparisons were then combined by the
previously described methods to obtain a single
overall result (6).
In additiontothesetests, one other set ofstatis-
tical analyses were carried for each primary tu-
mor: the Fisher exact test based on the overall
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proportion of tumor-bearing animals(7). All re-
ported p values are one-sided. Except where
noted, the three alternative analyses gave simi-
lar results.
Results
Establishment ofTest Groups
The experiment was designed to evaluate the
effects of orally ingested amosite or chrysotile
asbestos during the entire life of the animal,
starting from the time it was able to eat solid
food. For this reason, the mated female hamsters
had been on the test diets for approximately 2
weeks when the first litters were born. Of the
females, 10-15% were not pregnant, aborted, or
their litters died immediately after birth. Several
more dams died after showing a prolapsed rectum
in the week following birth. The incidences of
infertility and neonatal deaths were unrelated to
the test diet. Tb minimize the chance that the
mothers would reject or cannibalize their young,
the litters were not handled during lactation.
Many ofthe pups which died during the nursing
period were cannibalized by their mothers. In
those pups in which a postmortem examination
was possible, the stomachs were typically without
food (milk), suggesting maternal rejection or in-
ability to compete with litter mates. None ofthese
observations were compound-related.
Approximately 2% ofthe offspring in all groups
died between weaning and 14 weeks of age due to
cage fighting or an enteritis of undetermined
origin. Histologically, the disease was compatible
with the acute form of proliferate ileitis ("wet
tail"), a common disease of hamsters. Combina-
tions of cage fighting and enteritis were also
observed. These deaths were not compound-
related, although cage fighting was more severe
in the SR chrysotile and its temporal control
group than in the other two portions ofthe study.
Replacement hamsters were incorporated intothe
groups (in additional cages) to maintain group
sizesuntil the animals were 12 weeks ofage; from
this time on, no additional hamsters were added
to the experimental groups. The extra hamsters
were killed.
Body Weights and Clinical Signs
Body weight gain was not adversely affected in
any dose group, including the group given 1,2-
dimethylhydrazine dihydrochloride (DMH). In
fact, both types of asbestos appeared to increase
body weight in most ofthe dosed groups.
No compound-related clinical signs were ob-
served during the entire study. Occasional skin
lesions and bite wounds were observed in both
sexes, but were more apparent in males; these
became less of a problem after the hamsters were
20 weeks of age.
Survival
Survival was not adversely affected by any of
the test diets with the possible exception ofDMH-
treated female hamsters. Survival rates were ac-
tually higher inthe amosite and SR and IR chrys-
otile groups relative to the temporal controls. The
median life-span offemales (control and treated)
was shorter than that ofcorresponding groups of
males (Table 7). The median survival of control
Tible 7. Median life span ofhamsters in oral asbestos study.
Group Sex Median life span, weeks
IR chrysotile control M 83
F 61
IR chrysotile M 86
F 59
SR chrysotile control M 77
F 57
SR chrysotile M 87
F 63a
DMH and IR chrysotile control M 82
F 57
DMH M 82
F 54b
IR chrysotile and DMH M 90
F 63a
Amosite control M 81
F 55
Amosite M 84
F 60
aSignificantly (p < 0.05) improved overall survival relative to controls (life table analysis).
bSignificantly (p < 0.05) reduced overall survival relative to controls (life table analysis).
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female groups was 55-61 weeks, compared to 77-
83 weeks for control male hamsters (Table 7).
Pathology
The number of hamsters available for histo-
pathologic examination is shown in Table 6. Most
animals not examined pathologically were ex-
cluded because of autolysis or cannibalization.
Review ofthe clinical records ofhamsters lost to
autolysis or cannibalization gave no indication
that these animals had neoplasia.
A variety ofneoplasms was observed in control
(Tables 8 and 9) and asbestos-exposed hamsters
(Tables 10-17). The proportion ofcontrol male or
female hamsters bearing primary tumors was not
statistically different among the four control
groups. Thus, statistical comparisons were made
with pooled controls as well as with temporal
controls. Overall, the male hamsters had a
slightly higher rate ofneoplasia thanthe females.
Those organs with greater than 4% incidence of
neoplasia in dosed or control groups were the
adrenal gland, pancreas (islets of Langerhans),
parathyroid, and reticuloendothelial system.
The only organ showing an increased rate of
neoplasia in chrysotile-exposed hamsters com-
pared to the controls was the adrenal cortex. In
male hamsters, the incidence of cortical adeno-
mas was significantly increased (p < 0.01) in the
SR and IR chrysotile groups compared with the
pooled controls but not in the DMH chrysotile or
amosite groups. None of the chrysotile groups
showed a significant (p < 0.05) increase in corti-
cal adenomas relative to their temporal control
groups. A similar increase in cortical adenomas
was observed in the female IR chrysotile group
compared with pooled controls, but this also
ceased to be significant when compared with the
temporal control group.
In only three other instances did specific tumor
types show significant effects relative to pooled or
temporal controls. The only statistically signifi-
cant (p < 0.05) difference in tumor incidence
observed in the amosite study was a decrease in
islet-cell adenomas observed in female hamsters.
Female hamsters administered SR chrysotile
showed a significantly (p < 0.05) decreased inci-
dence ofislet-cell adenoma relative to pooled con-
trols (Table 16). Male hamsters administered
DMH showed a significantly (p < 0.05) increased
incidence of leukemia or malignant lymphoma
relative to pooled controls (Table 16).
The only group to show a significant (p < 0.05)
increase in overall primary tumors was the male
IR chrysotile group. This increase was due pri-
marily to adrenal tumors. Male hamsters receiv-
ing SR chrysotile or DMH and IR chrysotile also
Table 8. Incidence ofprimary tumors in male hamster control groups.
Animals with primary tumors
Skin or subcutaneous tissue, all tumors
Lung or trachea, all tumors
Adrenal
Cortical adenoma
Cortical carcinoma
Pheochromocytoma
Other tumors
Pancreas
Islet-cell adenoma
Islet-cell carcinoma
Thyroid
C-cell adenoma
C-cell carcinoma
Other tumors
Parathyroid, adenoma
G.I. tract, all tumors
Pituitary, all tumors
Kidney, all tumors
Liver, all tumors
Leukemia or malignant lymphoma
Hemangioma or hemangiosarcoma
All other tumors
Short-range
chrysotile
control
21/115 (18%)
0/115 (0%)
0/115 (0%)
7/115 (6%)
3/115 (3%)
2/115 (2%)
0/115 (0%)
2/111 (2%)
1/111 (1%)
3/109 (3%)
1/109 (1%)
0/109 (0%)
0/72 (0%)
2/115 (2%)
0/84 (0%)
0/115 (0%)
0/115 (0%)
2/115 (2%)
0/115 (0%)
1/115 (1%)
Intermediate-
range
chrysotile
control
26/116 (22%)
1/116 (1%)
0/116 (0%)
7/115 (6%)
3/115 (3%)
5/115 (4%)
3/115 (3%)
7/110 (6%)
0/110 (0%)
3/106 (3%)
1/106 (1%)
0/106 (0%)
1/71 (1%)
1/116 (1%)
0/77 (0%)
2/116 (2%)
0/116 (0%)
1/116 (1%)
0/116 (0%)
0/116 (0%)
DMH and
intermediate-
range
chrysotile
control
27/119 (23%)
1/119 (1%)
9/119 (0%)
3/117 (3%)
4/117 (3%)
3/117 (3%)
2/117 (2%)
8/110 (7%)
0/110 (0%)
0/107 (0%)
0/107 (0%)
1/107 (1%)
1/64 (2%)
2/119 (2%)
0/80 (0%)
1/119 (1%)
0/119 (0%)
4/119 (3%)
3/119 (3%)
3/119 (3%)
Amosite
control
21/122 (17%)
0/122 (0%)
0/120 (0%)
8/119 (7%)
3/119 (3%)
3/119 (3%)
1/119 (1%)
3/114 (3%)
0/114 (0%)
1/106 (1%)
1/106 (1%)
0/106 (0%)
0/64 (0%)
1/112 (1%)
0/81 (0%)
1/120 (1%)
0/120 (0%)
1/122 (1%)
2/122 (2%)
1/122 (1%)
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showed an elevated incidence ofprimary tumors
relative to pooled controls. However, when sur-
vival differences were taken into account by a life
table analysis, these differences were not statisti-
cally significant. Female chrysotile groups
showedlittle evidence ofan increased incidence of
primary tumors relative to temporal or pooled
controls.
Table 9. Incidence ofprimary tumors in female hamster control groups.
Animals with primary tumors
Skin or subcutaneous tissue, all tumors
Lung or trachea, all tumors
Adrenal
Cortical adenoma
Cortical carcinoma
Pheochromocytoma
Other tumors
Pancreas
Islet-cell adenoma
Islet-cell carcinoma
Thyroid
C-cell adenoma
C-cell carcinoma
Other tumors
Parathyroid, adenoma
G.I. tract, all tumors
Pituitary, all tumors
Kidney, all tumors
Liver, all tumors
Leukemia or malignant lymphoma
Hemangioma or hemangiosarcoma
Uterus, all tumors
All other tumors
Short-range
chrysotile
control
19/114 (17%)
0/114 (0%)
0/114 (0%)
4/112 (4%)
0/112 (0%)
0/112 (0%)
0/112 (0%)
2/109 (2%)
1/109 (1%)
2/106 (2%)
1/107 (0%)
2/107 (2%)
3/68 (4%)
1/114 (1%)
0/77 (0%)
0/114 (0%)
0/114 (0%)
2/114 (2%)
0/114 (0%)
3/113 (3%)
3/114 (3%)
Intermediate-
range
chrysotile
control
17/119 (14%)
1/119 (0%)
0/119 (0%)
6/118 (5%)
0/118 (0%)
0/118 (0%)
0/118 (0%)
5/116 (4%)
0/116 (0%)
3/115 (3%)
1/115 (0%)
0/115 (0%)
1/77 (1%)
2/119 (2%)
2/67 (3%)
1/119 (1%)
0/119 (0%)
1/119 (0%)
0/119 (0%)
1/119 (1%)
0/119 (0%)
DMH and
intermediate-
range
chrysotile
control
15/120 (12%)
1/120 (0%)
0/119 (0%)
3/120 (2%)
0/120 (0%)
0/120 (0%)
0/120 (0%)
5/116 (4%)
0/116 (0%)
0/112 (0%)
0/112 (1%)
1/112 (0%)
1/74 (1%)
1/120 (1%)
0/62 (0%)
0/120 (0%)
0/119 (0%)
3/120 (2%)
1/120 (1%)
2/120 (2%)
1/120 (1%)
Amosite
control
15/119 (13%)
0/119 (0%)
0/119 (0%)
2/118 (2%)
0/118 (0%)
0/118 (0%)
0/118 (0%)
3/115 (3%)
0/115 (0%)
1/106 (1%)
1/106 (0%)
0/106 (0%)
1/61 (1%)
1/119 (1%)
0/79 (0%)
0/119 (0%)
0/118 (0%)
2/119 (2%)
1/119 (1%)
2/119 (2%)
2/119 (2%)
Table 10. Incidence ofprimary tumors in male hamsters administered amosite asbestos.
Pooled Amosite Amosite-
controls controls treated
Animals with primary tumors 95/472 (20%) 21/122 (17%) 57/248 (23%)
Skin or subcutaneous tissues,
all tumors 2/472 (<1%) 0/122 (0%) 0/248 (0%)
Lung and trachea, all tumors 0/470 (0%) 0/120 (0%) 0/248 (0%)
Adrenal
Cortical adenoma 25/466 (5%) ) 8/119 (7%) 13/246 (5%)
Cortical carcinoma 13/466 (3%) 3/119 (3%) 7/246 (3%)
Pheochromocytoma 13/466 (3%) 3/119 (3%) 4/246 (2%)
Other tumors 6/466 (1%) 1/119 (1%) 2/246 (1%)
Pancreas
Islet-cell adenoma 20/455 (4%) 3/114 (3%) 11/234-(5%)
Islet-cell carcinoma 1/445 (<1%) 0/114 (0%) 0/234 (0%)
Thyroid
C-cell adenoma 7/428 (2%) 1/106 (1%) 7/221 (3%)
C-cell carcinoma 1/428 (<1%) 0/106 (0%) 2/221 (1%)
Other tumors 1/428 (<1%) 0/106 (0%) 2/221 (1%)
Parathyroid, ademona 2/271 (1%) 0/64 (0%) 2/150 (1%)
G.I. tract, all tumors 6/472 (1%) 1/122 (1%) 6/248 (2%)
Pituitary, all tumors 0/322 (0%) 0/81 (0%) 0/182 (0%)
Kidney, all tumors 4/470 (1%) 1/120 (1%) 2/248 (1%)
Liver, all tumors 0/470 (0%) 0/120 (0%) 0/247 (0%)
Leukemia or malignant lymphoma 8/472 (2%) 1/122 (1%) 5/248 (2%)
Hemangioma orhemangiosarcoma 5/472 (1%) 2/122 (2%) 2/248 (1%)
All other tumors 5/472 (1%) 1/122 (1%) 2/248 (1%)
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Table 11. Incidence ofprimary tumors in female hamsters administered amosite asbestos.
Pooled Amosite Amosite-
controls controls treated
Animals with primary tumors 66/472 (14%) 15/119 (13%) 30/237 (13%)
Skin or subcutaneous tissues,
all tumors 0/472 (0%) 0/119 (0%) 2/237 (1%)
Lung and trachea, all tumors 0/471 (0%) 0/119 (0%) 0/234 (0%)
Adrenal
Cortical adenoma 15/468 (3%) 2/118 (2%) 6/234 (3%)
Cortical carcinoma 0/468 (0%) 0/118 (0%) 0/234 (0%)
Pheochromocytoma 0/468 (0%) 0/118 (0%) 2/234 (1%)
Other tumors 0/468 (0%) 0/118 (0%) 0/234 (0%)
Pancreas
Islet-cell adenoma 15/456 (3%) 3/115 (3%) 2/222 (1%)*
Islet-cell carcinoma 0/222 (0%) 0/115 (0%) 1/456 (1%)
Thyroid
C-cell adenoma 6/440 (1%) 1/106 (1%) 4/215 (2%)
C-cell carcinoma 1/440 (<1%) 0/106 (0%) 1/215 (<1%)
Other tumors 2/440 (1%) 0/106 (0%) 0/215 (0%)
Parathyroid, ademona 6/280 (2%) 1/61 (1%) 1/141 (1%)
G.I. tract, all tumors 5/472 (1%) 1/119 (1%) 4/237 (2%)
Pituitary, all tumors 2/285 (1%) 0/79 (0%) 0/149 (0%)
Kidney, all tumors 1/472 (<1%) 1/119 (0%) 0/236 (0%)
Liver, all tumors 0/472 (0%) 0/118 (0%) 0/234 (0%)
Leukemia or malignant lymphoma 7/472 (1%) 2/119 (2%) 3/2236 (1%)
Hemangioma or hemangiosarcoma 2/472 (<1%) 1/119 (1%) 3/237 (1%)
Uterus, all tumors 8/471 (2%) 2/119 (1%) 1/236 (<1%)
All other tumors 6/472 (1%) 1/119 (1%) 2/237 (1%)
*p < 0.05 decrease relative to pooled controls (life table and incidental tests).
Table 12. Incidence ofprimary tumors in male hamsters administered short-range chrysotile asbestos.
Short-range
Pooled chrysotile Short-range
controls controls chrysotile
Animals with primary tumors 95/472 (20%) 21/115 (18%) 64/233 (27%)a
Skin or subcutaneous tissue, all tumors 2/472 (<1%) 0/115 (0%) 0/233 (0%)
Lung or trachea, all tumors 0/470 (0%) 0/115 (0%) 0/231 (0%)
Adrenal
Cortical adenoma 25/466 (5%) 7/115 (6%) 26/229 (11%)b
Cortical carcinoma 13/466 (3%) 3/115 (3%) 8/229 (3%)
Pheochromocytoma 13/466 (3%) 2/115 (2%) 4/229 (2%)
Other tumors 6/466 (1%) 0/115 (0%) 1/229 (<1%)
Pancreas
Islet-cell adenoma 20/445 (4%) 2/111 (2%) 15/218 (7%)
Islet-cell carcinoma 1/445 (<1%) 1/111 (1%) 0/218 (0%)
Thyroid
C-cell adenoma 7/428 (2%) 3/109 (3%) 3/207 (1%)
C-cell carcinoma 3/428 (1%) 1/109 (1%) 1/207 (<1%)
Other tumors 1/428 (<1%) 0/109 (0%) 0/207 (0%)
Parathyroid, adenoma 2/271 (1%) 0/72 (0o) 3/132 (2%)
G.I. tract, all tumors 6/472 (1%) 2/115 (2%) 0/233 (0%)
Pituitary, all tumors 0/322 (0%) 0/84 (0%) 0/159 (0%)
Kidney, all tumors 4/470 (1%) 0/115 (0%) 3/232 (1%)
Liver, all tumors 0/470 (0%) 0/115 (0%) 0/232 (0%)
Leukemia or malignant lymphoma 8/472 (2%) 2/115 (2%) 3/233 (1%)
Hemangioma or hemangiosarcoma 5/472 (1%) 0/115 (0%) 4/233 (2%)
All other tumors 5/472 (1%) 1/115 (1%) 3/233 (1%)
ap < 0.05 vs. pooled controls.
bp = 0.152 (life table);p = 0.065 (incidental tumor test) andp = 0.019 (Fisher's exact test) vs. pooled controls.
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Table 13. Incidence ofprimary tumors in female hamsters administered short-range chrysotile asbestos.
Short-range
Pooled chrysotile Short-range
controls controls chrysotile
Animals with primary tumors 66/472 (14%) 19/114 (17%) 28/228 (12%)
Skin or subcutaneous tissue, all tumors 0/472 (0%) 0/114 (0%) 3/228 (1%)
Lung or trachea, all tumors 0/471 (0%) 0/114 (0%) 0/228 (0%)
Adrenal
Cortical adenoma 15/468 (3%) 4/112 (4%) 8/226 (4%)
Cortical carcinoma 0/468 (0%) 0/112 (0%) 0/226 (0%)
Pheochromocytoma 0/468 (0%) 0/112 (0%) 3/226 (1%)
Other tumors 0/468 (0%) 0/112 (0%) 1/226 (<1%)
Pancreas
Islet-cell adenoma 15/456 (3%) 2/109 (2%) 2/217 (1%)a
Islet-cell carcinoma 1/456 (<1%) 1/109 (1%) 0/217 (0%)
Thyroid
C-cell adenoma 6/440 (1%) 2/107 (2%) 0/214 (0%)
C-cell carcinoma 1/440 (<1%) 1/107 (0%) 0/214 (0%)
Other tumors 2/440 (<1%) 2/107 (2%) 0/214 (0%)
Parathyroid, adenoma 6/280 (2%) 3/68 (4%) 3/139 (2%)
G.I. tract, all tumors 5/472 (1%) 1/114 (1%) 1/228 (<1%)
Pituitary, all tumors 2/285 (1%) 0/77 (0%) 0/132 (1%)
Kidney, all tumors 1/472 (<1%) 0/114 (0%) 0/228 (0%)
Liver, all tumors 0/472 (0%) 0/114 (0%) 0/228 (0%)
Leukemia or malignant lymphoma 7/472 (1%) 2/114 (2%) 2/228 (1%)
Hemangioma or hemangiosarcoma 2/472 (<1%) 0/114 (0%) 1/228 (<1%)
Uterus, all tumors 8/471 (2%) 3/113 (3%) 5/226 (2%)
All other tumors 6/472 (1%) 3/114 (3%) 3/228 (1%)
ap < 0.05 decrease relative to pooled controls (life table and incidental tumor test).
Tble 14. Incidence ofprimary tumors in male hamsters administered intermediate-range chrysotile asbestos.
Animals with primary tumors
Skin or subcutaneous tissue, all tumors
Lung or trachea, all tumors
Adrenal
Cortical adenoma
Cortical carcinoma
Pheochromocytoma
Other tumors
Pancreas
Islet-cell adenoma
Islet-cell carcinoma
Thyroid
C-cell adenoma
C-cell carcinoma
Other tumors
Parathyroid, adenoma
G.I. tract, all tumors
Pituitary, all tumors
Kidney, all tumors
Liver, all tumors
Leukemia or malignant lymphoma
Hemangioma orhemangiosarcoma
All other tumors
Pooled
controls
95/472 (20%)
2/472 (<1%)
0/470 (0%)
25/466 (5%)
13/466 (3%)
13/466 (3%)
6/466 (1%)
20/445 (4%)
1/445 (<1%)
7/428 (2%)
3/428 (1%)
1/428 (<1%)
2/271 (1%)
6/472 (1%)
0/322 (0%)
4/470 (1%)
0/470 (0%)
8/472 (2%)
5/472 (1%)
5/472 (1%)
Intermediate-
range
chrysotile
controls
26/116 (22%)
1/116 (1%)
0/116 (0%)
7/115 (6%)
3/115 (3%)
5/115 (4%)
3/115 (3%)
7/110 (6%)
0/110 (0%)
3/106 (3%)
1/106 (1%)
0/106 (0%)
1/71 (1%)
1/116 (1%)
0/77 (0%)
2/116 (2%)
0/116 (0%)
1/116 (1%)
0/116 (0%)
0/116 (0%)
Intermediate-
range
chrysotile
78/245 (32%)a,b
0/245 (0%)
1/244 (<1%)
24/244 (10%)c
7/244 (3%)
11/244 (5%)
1/244 (<1%)
15/226 (7%)
1/226 (<1%)
5/216 (2%)
4/216 (2%)
1/216 (<1%)
4/138 (3%)
3/245 (1%)
0/182 (0%)
1/245 (<1%)
0/244 (0%)
10/245 (4%)
1/242 (<1%)
2/245 (1%)
ap < 0.01 vs. pooled controls.
bp < 0.05 vs. intermediate-range chrysotile controls.
cp < 0.05 vs. pooled controls.
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Table 15. Incidence ofprimary tumors in female hamsters administered intermediate-range chrysotile asbestos.
Intermediate-
range Intermediate-
Pooled chrysotile range
controls controls chrysotile
Animals with primary tumors 66/472 (14%) 17/119 (14%) 39/244 (16%)
Skin or subcutaneous tissue, all tumors 0/472 (0%) 0/119 (0%) 2/244 (1%)
Lung or trachea, all tumors 0/471 (0%) 0/119 (0%) 0/243 (0%)
Adrenal
Cortical adenoma 15/468 (3%) 6/118 (5%) 18/234 (8%)a
Cortical carcinoma 0/468 (0%) 0/118 (0%) 1/234 (<1%)
Pheochromocytoma 0/468 (0%) 0/118 (0%) 1/234 (<1%)
Other tumors 0/468 (0%) 0/118 (0%) 0/234 (0%)
Pancreas
Islet-cell adenoma 15/456 (3%) 5/116 (6%) 4/236 (2%)
Islet-cell carcinoma 1/456 (<1%) 0/116 (0%) 0/236 (0%)
Thyroid
C-cell adenoma 6/440 (1%) 3/115 (3%) 2/223 (1%)
C-cell carcinoma 1/440 (<1%) 0/115 (0%) 0/223 (0%)
Other tumors 2/440 (<1%) 0/115 (0%) 1/223 (<1%)
Parathyroid, adenoma 6/280 (2%) 1/77 (1%) 1/148 (1%)
G.I. tract, all tumors 5/472 (1%) 2/119 (2%) 1/244 (<1%)
Pituitary, all tumors 2/285 (1%) 2/67 (3%) 2/164 (1%)
Kidney, all tumors 1/472 (<1%) 1/119 (1%) 0/243 (0%)
Liver, all tumors 0/472 (0%) 0/119 (0%) 0/234 (0%)
Leukemia or malignant lymphoma 7/472 (1%) 0/119 (0%) 2/244 (1%)
Hemangioma or hemangiosarcoma 2/472 (<1%) 0/119 (0%) 1/244 (<1%)
Uterus, all tumors 8/471 (2%) 1/119 (1%) 7/240 (3%)
All other tumors 6/472 (1%) 0/119 (0%) 2/244 (1%)
ap < 0.05 vs. pooled controls.
Table 16. Incidence ofprimary tumors in male hamsters administered 1,2-dimethylhydrazine dihydrochloride (DMH)
or intermediate-range chrysotile asbestos and DMH.
DMH and
intermediate- DMH and
range intermediate-
Pooled chrysotile range
controls controls DMH chrysotile
Animals with primary tumors 95/472 (20%) 27/119 (23%) 29/127 (23%) 51/173 (29%)a
Skin or subcutaneous tissue, all tumors 2/472 (<1%) 1/119 (1%) 0/127 (0%) 1/173 (1%)
Lung or trachea, all tumors 0/470 (0%) 0/119 (0%) 0/126 (0%) 0/173 (0%)
Adrenal
Cortical adenoma 25/466 (5%) 3/117 (3%) 3/127 (2%) 8/171 (5%)
Cortical carcinoma 13/466 (3%) 4/117 (4%) 2/127 (2%) 7/171 (4%)
Pheochromocytoma 13/466 (3%) 3/117 (3%) 4/127 (3%) 6/171 (4%)
Other tumors 6/466 (1%) 2/117 (2%) 0/127 (0%) 1/171 (1%)
Pancreas
Islet-cell adenoma 20/445 (4%) 8/110 (7%) 6/114 (5%) 10/167 (6%)
Islet-cell carcinoma 1/445 (<1%) 0/110 (0%) 0/114 (0%) 1/167 (1%)
Thyroid
C-cell adenoma 7/428 (2%) 0/107 (0%) 2/118 (2%) 3/163 (2%)
C-cell carcinoma 3/428 (1%) 0/107 (0%) 0/118 (0%) 1/163 (1%)
Other tumors 1/428 (<1%) 1/107 (1%) 0/118 (0%) 0/163 (0%)
Parathyroid, adenoma 2/271 (1%) 1/64 (2%) 0/81 (0%) 2/118 (2%)
G.I. tract, all tumors 6/472 (1%) 2/119 (2%) 3/127 (2%) 4/173 (2%)
Pituitary, all tumors 0/322 (0%) 0/80 (0%) 0/87 (1%) 2/123 (2%)
Kidney, all tumors 4/470 (1%) 1/119 (1%) 0/127 (0%) 0/173 (0%)
Liver, all tumors 0/470 (0%) 0/119 (0%) 2/127 (2%) 1/173 (1%)
Leukemia or malignant lymphoma 8/472 (2%) 4/119 (4%) 7/127 (6%)b 8/173 (5%)
Hemangioma or hemangiosarcoma 5/472 (1%) 3/119 (3%) 2/127 (2%) 2/173 (1%)
All other tumors 5/472 (1%) 3/119 (3%) 1/127 (1%) 4/173 (2%)
ap = 0.257 (life table); p = 0.038 (incidental tumortest); p = 0.009 (Fisher's exact test) vs. pooled controls.
bp < 0.05 vs. pooled controls.
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(DMH) orintermediate-range chrysotile asbestos and DMH.
DMH and
intermediate- DMH and
range intermediate-
Pooled chrysotile range
controls controls DMH chrysotile
Animals with primary tumors 66/472 (14%) 15/120 (12%) 15/122 (12%) 19/161 (12%)
Skin or subcutaneous tissue, all tumors 0/472 (0%) 0/120 (0%) 1/122 (1%) 0/161 (0%)
Lung or trachea, all tumors 0/471 (0%) 0/119 (0%) 0/122 (0%) 1/160 (1%)
Adrenal
Cortical adenoma 15/468 (3%) 3/120 (2%) 2/120 (2%) 6/158 (4%)
Cortical carcinoma 0/468 (0%) 0/120 (0%) 0/120 (0%) 2/158 (1%)
Pheochromocytoma 0/468 (0%) 0/120 (0%) 0/120 (0%) 0/158 (0%)
Other tumors 0/468 (0%) 0/120 (0%) 0/120 (0%) 0/158 (0%)
Pancreas
Islet-cell adenoma 15/456 (3%) 5/116 (4%) 2/119 (2%) 4/149 (3%)
Islet-cell carcinoma 1/456 (<1%) 0/116 (0%) 0/119 (0%) 1/149 (0%)
Thyroid
C-cell adenoma 6/440 (1%) 0/112 (0%) 0/108 (0%) 0/141 (0%)
C-cell carcinoma 1/440 (<1%) 1/112 (1%) 0/108 (0%) 0/141 (0%)
Other tumors 2/440 (<1%) 1/112 (0%) 0/108 (0%) 0/141 (0%)
Parathyroid, adenoma 6/280(2%) 1/74 (1%) 2/57 (4%) 0/91 (0%)
G.I. tract, all tumors 5/472 (1%) 1/120 (1%) 2/122 (2%) 0/161 (0%)
Pituitary, all tumors 2/285 (1%) 0/62 (0%) 0/59 (0%) 0/109 (0%)
Kidney, all tumors 1/472 (<1%) 0/120 (0%) 0/122 (0%) 0/161 (0%)
Liver, all tumors 0/472 (0%) 0/119 (0%) 0/121 (0%) 0/161 (0%)
Leukemia or malignant lymphoma 7/472 (1%) 3/120 (2%) 2/122 (2%) 3/161 (2%)
Hemangioma orhemangiosarcoma 2/472 (<1%) 1/120 (1%) 0/122 (0%) 1/161 (1%)
Uterus, all tumors 8/471 (2%) 2/120 (2%) 2/116 (2%) 2/156 (1%)
All other tumors 6/472 (1%) 1/120 (1%) 2/122 (2%) 2/161 (1%)
Table 18. Incidence ofgastrointestinal tract tumors in hamsters administered amosite asbestos.
Pooled Amosite Amosite-
controls controls treated
M F M F M F
Stomach (number examined) (464) (468) (120) (117) (247) (236)
Squamous cell papilloma 3 0 1 0 4 0
Papilloma 0 0 0 0 0 3
Small intestine (number examined) (467) (469) (120) (117) (246) (236)
Adenoma 1 0 0 0 0 0
Adenocarcinoma 1 0 0 0 0 0
Large intestine (number examined) (464) (468) (118) (116) (246) (235)
Adenoma 0 1 0 0 0 0
Papillary adenoma 0 0 0 0 1 0
Adenocarcinoma 0 1 0 0 0 0
Lipoma 0 1 0 0 0 0
Rectum (number examined) (472) (272) (122) (119) (248) (237)
Adenoma 1 1 0 1 0 0
Adenomatous polyp 0 0 0 0 1 0
Fibroma 0 1 0 0 0 0
Squamous cell papilloma 0 0 0 0 0 0
Males and females administered DMH did not
show a significant (p < 0.05) increase in intesti-
nal neoplasia. Nor did the intermediate-range
chrysotile produce a higher rate ofintestinal neo-
plasia in DMH-dosed animals. A summary of all
gastrointestinal tumors observed in this study is
given in Tables 18 and 19. None of the treated
groups showed an increased rate of neoplasia in
the gastrointestinal tract which was the proposed
target organ.
While this study was not designed to evaluate
nonneoplastic disease, noteworthy lesions were
observed. None appeared to be dosage related;
rather, they were consistent with lesions that are
normally found in aging hamsters. It was the
pathologists' opinion that the most important le-
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Jble 19. Incidence ofgastrointestinal tract tumors in hamsters administered chrysotile asbestos.
Stomach (number examined)
Squamous cell papilloma
Carcinoma in situ
Papillary adenoma
Small intestine (number examined)
Adenoma
Adenomacarcinoma
Large intestine (number examined)
Papilloma
Adenoma
Papillary adenoma
Adenocarcinoma
Lipoma
Adenomatous polyp
Rectum (number examined)
Adenoma
Papillary adenoma
Fibrosarcoma
Squamous cell carcinoma
Fibroma
Pooled
controls
M F
(464) (468)
3 0
o o
o 0
(467) (469)
1 0
1 0
(464) (468)
o o
0 1
o o
0 1
0 1
o o
(472) (472)
1 1
o 0
o o
o o
0 1
Short-range
chrysotile
M F
(222) (224)
o 0
o o
o o
(226) (227)
o 0
o o
(222) (226)
o o
o o
o 0
0 1
o o
o o
(233) (228)
o o
o o
o o
o o
o o
sion, responsible for many deaths, was general-
ized amyloidosis. The kidneys were particularly
affected by diffuse accumulation of amyloid,
which replaced glomeruli and infiltrated tubular
interstitium to a point where the normal cortical
architecture was obliterated. Other organs which
showed significant accumulations of amyloid
were adrenal gland, liver, spleen and the epithe-
lium of the small intestine. Amyloid within the
walls ofblood vessels was observed in many tis-
sues.
Many of the livers were cirrhotic, infiltrated
with amyloid, and contained large cystic struc-
tures filled with a lightly staining proteinaceous
fluid. These structures were interpreted as cystic
bile ducts and are consistent with what others
have termed "retention cysts." At times, these
cysts were so large and/or numerous that less
than halfofthe livers remained.
Othernonneoplastic lesions that were observed
in more than 5% of the hamsters in any of the
experimental groups are as follows: (1) skin,
chronic dermitis; (2) lung, interstitial pneumoni-
tis; (3) spleen, lymphoid atrophy; (4) lymph node,
hyperplasia; (5) heart, atrial thrombosis; (6) gall-
bladder, edema andcalculi; (7) stomach (nonglan-
dular), hyperkeratosis or acanthosis; (8) colon,
intussusception, inflammation; (9) urinary blad-
der, chronic inflammation, hyperplasia; (10) adre-
nal gland, cortical and medullary hyperplasia;
(11) thyroid gland, follicular atrophy; (12) pitui-
Intermediate-
range
chrysotile
M F
(244) (242)
1 0
1 0
1 1
(244) (244)
o 0
o 0
(241) (243)
o 0
o o
o o
o o
o o
o 0
(245) (244)
o 0
o o
o o
o o
o 0
DMH and
Intermediate-
range
DMH chrysotile
M F M F
(127)
0
0
0
(127)
0
0
(126)
0
1
1
0
0
0
(127)
0
0
1
0
0
(118)
0
0
0
(120)
0
0
(118)
0
0
0
0
0
1
(122)
0
0
0
1
0
(170)
2
0
0
(170)
0
0
(170)
1
0
0
0
0
0
(173)
0
1
0
0
0
(160)
0
0
0
(159)
0
0
(159)
0
0
0
0
0
0
(161)
0
0
0
0
0
tary gland, degeneration; (13) ovary, atrophy;
(14) uterus, inflammation, endometrial hyperpla-
sia; (15) vagina, acute inflammation, squamous
metaplasia.
Discussion
The clinicopathologic results in this study
showed that the chronic ingestion of 1% amosite
(8) or chrysotile (SR and IR) (9) asbestos in the
diet did not have any adverse effect on body
weight gain and survival seemed to be enhanced.
An explanation for these observations is not ap-
parent.
The major organ which showed a statistically
significant (p < 0.05) increased rate ofneoplasia
was the adrenal cortex in male and female ham-
sters exposed to IR chrysotile asbestos and males
exposed to SR chrysotile asbestos when compared
with pooled controls. However, statistical signifi-
cance was lost when these groups were compared
to their temporal controls. It is difficult to imag-
ine how oral asbestos, even though it is known to
be absorbed through the gastrointestinal tract
(10), could cause an increased tumor rate in the
adrenal cortex without causing similar increases
in tumors in other abdominal organs and tissues,
i.e., gastrointestinal tract and peritoneum. For
these reasons, the biologic importance ofadrenal
tumors in this study is doubtful. The overall in-
crease in total primary tumors in male IRchryso-
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tile hamsters can be explained primarily on the
basis ofan increased incidence ofadrenal tumors
in this group. The enhanced survival of animals
in the chrysotile groups also contributed to the
elevated incidence ofprimary tumors observed in
these groups compared with controls.
The only other instance ofan increased rate of
neoplasia was a significant (p < 0.05) increase in
leukemia or malignant lymphoma in male ham-
sters exposed to DMH when compared to pooled
controls. Again, statistical significance was lost
when this group was compared to its temporal
control group. This finding also loses importance
because it was not observed in the DMH plus IR
chrysotile group.
Other such studies involving the long-term in-
gestion of asbestos are few. Donham et al. (11)
reported equivocal results in F344 rats which
were fed adiet containing 10% chrysotile fortheir
lifetime. While they didnot observe a statistically
significant (p < 0.05) increase in the number of
tumors in exposed animals, the authors believed
that there was a trend toward increased colon
lesions in general, evidence of penetration of as-
bestos into the colonic mucosa and possible cyto-
toxicity to colonic tissues and they suggested a
possible relationship to peritoneal mesothelioma.
Another equivocal study is that reportedby Gibel
et al. (12), who described an increase in malig-
nant tumors in the lung, kidney, liver and reticu-
loendothelial system, but no increase in intesti-
nal neoplasia in Wistar rats fed asbestos filter
material (20 mg/day) for a period of8-14 months.
Cunningham et al. (13) reported two studies in
male Wistar rats administered 1% chrysotile in
the diet, one study of 24 months and one of 30
months. No increase in intestinal tumors was
found compared to the control rats. Negative
results were reported by Gross et al. (14), who fed
rats a diet containing 5% chrysotile asbestos for a
period of21 months with no evidence ofintestinal
neoplasia.
The only oral asbestos study in hamsters was
reported by Smith et al. (15). They exposed
groups of30 male and female hamsters via drink-
ing water for lifetime to amosite asbestos, mine
tailings, beach rock, and Lake Superior drinking
water. They did not observe adverse effects on
body weight or survival time in any ofthe groups.
A peritoneal mesothelioma, one pulmonary carci-
noma, and two early squamous cell carcinomas of
the nonglandular stomach were found in the
hamsters exposed to amosite, but the incidence
was not statistically significant (p < 0.05). Their
other studies were considerednegative. They con-
cluded that the study was essentially negative.
Except for those by Donham et al. (11) and
Smith et al. (15), these studies were conducted
with relatively small numbers of animals. Also,
some were conducted for periods of time insuffi-
cient for adequately testing the carcinogenic po-
tential ofingested asbestos.
The results ofthe combination study (IR chrys-
otile plus DMH) also did not yield a significant
increase in tumors above the background level
observed in the DMH group alone or in the un-
treated control group. The DMH failed to yield a
background level of intestinal tumors high
enough to provide a valid test of the cocarcino-
genic potential of chrysotile asbestos. For this
reason, a cocarcinogenic potential oforal asbestos
should be considered untested. However, the
DMH plus chrysotile provides an additional IR
chrysotile group for comparative purposes.
It is not clear why the DMH-dosed group of
hamsters failed to show an increased incidence of
intestinal neoplasia. The pilot study suggested
that this dose of DMH should have caused an
incidence of approximately 15%. DMH solutions
rapidly decompose if they are at room tempera-
ture or ifthey are not properly buffered.
The only long-term study designed to deter-
mine the cocarcinogenic potential ofasbestos was
reported by Ward et al. (16). They administered 1
mg amosite asbestos in saline by gavage to 6-
week-old F344 rats three times per week for 10
weeks. Once per week during this same period,
half of the rats received subcutaneous injections
of 7.4 mg/kg azoxymethane (AOM), a known in-
testinal carcinogen in animals. All surviving rats
were killed at 94-95 weeks ofage. They reported
an intestinal tumor incidence of 66.7% for AOM
alone, 77.1% foramosite plus AOM, and 32.6% for
amosite alone. The authors concluded that while
amosite did not significantly add to the incidence
of AOM-induced intestinal neoplasia, amosite
alone caused a relatively high rate of intestinal
neoplasia. However, there was no untreated con-
trol group with which to compare the treated
groups. These results should as well be viewed
with some suspicion because the authors also
reported a 14% incidence ofZymbal gland tumors
in the rats exposed to amosite alone. The histori-
cal rate ofZymbal gland tumors in the Bioassay
Program is 0.34%, indicating that this is an un-
common spontaneous tumor. However, AOM is
known to induce Zymbal gland tumors with a
single dose of5.1 mg/kg inmale F344 ratsproduc-
ing a 14% incidence oftumors in this organ (17);
in this study 5.1 mg/kg AOM also caused a 24%
incidence ofintestinal neoplasia. An appropriate
explanation for the high incidence of Zymbal
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gland tumors in the amosite group would be that
those animals were inadvertently exposed to
AOM. If this occurred, animals would also be
expected to show a high incidence of intestinal
neoplasia.
Conclusion
Under the conditions of this bioassay, amosite
asbestos and short-range chrysotile and interme-
diate-range chrysotile asbestos were not carcino-
genic when ingested by male and female Syrian
golden hamsters. While there were significant
increases in the rates of adrenal cortical adeno-
mas in male and female hamsters exposed to
intermediate-range chrysotile asbestos compared
with pooled control groups, these incidence rates
were not significantly different when compared
with the temporal control groups. Additionally,
the biological importance of adrenal tumors in
the absence oftarget organ neoplasia is question-
able. The cocarcinogen studies using IR chryso-
tile asbestos and 1,2-dimethylhydrazine dihydro-
chloride were considered inadequate because
there was no increase in intestinal neoplasia in
the DMH group.
The animal phase of this study was performed at the IIT
Research Institute, Chicago, IL. This project has been funded
withfederal funds from the National Institute ofEnvironmen-
tal Health Sciences (NIH), Department ofHealth and Human
Services, Research ¶friangle Park, NC, under contract #NO1-
ES-5-2157. Partial funding was provided by the Environmen-
tal Protection Agency under Interagency Agreement No.
D70756.
The research described in this paper has been peer and
administratively reviewed by the U.S. Environmental Protec-
tion Agency and approved for presentation and publication.
Mention of trade names or commercial products does not
constitute endorsement or recommendation for use.
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